Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in India / NCT07557277
Recruiting Observational

Gingival Recession and Oral Health-related Quality of Life: A Cross-sectional Study

NCT07557277 · tracked via the Priya Life Science India tracker
Sponsor
Postgraduate Institute of Dental Sciences Rohtak
Phase
Observational
Started
2026-03-15
Last updated
2026-04-29

Condition(s) studied

Gingival Recession

Investigational drug(s) / intervention(s)

Systemically healthy individuals 18-45 years of age, having gingival recession

Systemically healthy individuals 18-45 years of age, having gingival recession: Oral health related quality of life will be recorded using oral health impact profile-14 questionnaire in patients having gingival recession

Study summary

Aim of this study is the assessment of gingival recession and its impact on oral health related quality of life in tertiary health care center in Haryana state.

Objectives:

1. Determine the prevalence of gingival recession (GR) through clinical screening.
2. Classify patients with GR based on the system proposed by Cairo et al.
3. Identify the risk factors associated with GR
4. To assess the impact of GR on oral health related quality of life.

Eligibility

Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18-45 years old; * Patients who are willing to participate in the study and ready to give informed consent. * Cases defined for GR will be done according to Cairo at el. * The minimum threshold for reporting the presence of gingival recession will be greater than or equal to 1 mm. Exclusion Criteria: * Systemic disease affecting the periodontal issues (e.g., bleeding disorders, diabetes mellitus etc.) * Patients under medication associated with gingival enlargement (e.g., calcium channel blockers, immunosuppressants or anticonvulsants). * Patients having masochistic habits (tongue thrusting, nail biting etc.) * Mobile teeth * Involved teeth with trauma from occlusion. * Involved teeth with prosthesis. * Endodontically involved/ RCT treated tooth * Patient undergoing/underwent orthodontic treatment

Primary outcome measure(s)

  • Oral health quality assessment — 12 months
    Oral health quality assessment will be recorded using oral health impact profile-14 questionnaire.
  • Prevalence of gingival recession — 12 months
    Prevalence of gingival recession will be categorised based on Cairo classification.

Trial sites (1)

FacilityCityRegionStatus
PGIDS, Rohtak Rohtak Haryana Recruiting

More Postgraduate Institute of Dental Sciences Rohtak trials in India

a Prospective Randomised Study Evaluating the Efficacy of Intranasal Midazolam and Dexmedetomidine as a Sedative Agent in Management of Mandible Fracture Enrolling by invitation
TO DETERMINE THE EFFECT OF ALLOGRAFT AND iPRF WITH OR WITHOUT COLLAGEN MEMBRANE ON HEALING OF APICOMARGINAL DEFECTS Recruiting
Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars Recruiting
Motivational Interviewing and Subgingival Instrumentation Outcomes in Periodontitis Starting soon
Comparative Evaluation of Periodontal Status and Periodontal Parameters in Different Age Group Individuals With and Without Trauma From Occlusion. Starting soon

Other trials for the same condition

Effect Of Microneedling With Coronally Advanced Flap For Management of RT1 Gingival Recession In Thin Gingival Phenotype Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07557277 on ClinicalTrials.gov ↗ ← All trials in India